ZNHIT1
ZNHIT1 (zinc finger HIT-type containing 1, also known as CG1I, ZNFN4A1 and p18(Hamlet)) is a nuclear protein that promotes incorporation of the histone variant H2A.Z into chromatin. Through this activity it regulates gene expression in stem cell maintenance, differentiation and the p53 response. Browse Assay Genie's current range of ZNHIT1 research reagents below, or read on for the biology behind the target.
ZNHIT1 plays a role in chromatin remodelling by promoting the incorporation of histone variant H2AZ1 (H2A.Z) into the genome, thereby regulating gene expression. It promotes SRCAP complex-mediated deposition of H2AZ1 and promotes phosphorylation of the H2AZ1 chaperone VPS72/YL1, which enhances the interaction between H2AZ1 and VPS72. Through H2AZ1 deposition it acts in several lineages: it enhances lymphoid commitment at lymphoid fate regulator genes, is recruited to the MYOG promoter early in muscle differentiation, and maintains haematopoietic stem cell quiescence by shaping chromatin accessibility at enhancers of genes such as PTEN, FSTL1 and KLF4.
The protein has further roles in tissue maintenance and development. It supports intestinal stem cell maintenance by promoting H2AZ1 deposition at genes including LGR5, TGFB1 and TGFBR2, and regulates entry of male germ cells into meiosis by facilitating expression of genes such as MEIOSIN. In the heart it is required for postnatal function, through control of CASQ1 and ATP2A2/SERCA2A expression and Ca(2+) homeostasis, and for mitochondrial maturation and oxidative metabolism during embryonic development. In neural cells it promotes neurite growth, and in the lens it contributes to fibre cell differentiation by regulating CDKN1A/p21Cip1.
ZNHIT1 is also linked to the p53 pathway. It stimulates transcription of proapoptotic p53 targets such as PMAIP1/NOXA and BBC3/PUMA, and enhances recruitment of p53 to the CDKN1A promoter during cell cycle arrest after gamma-irradiation. It can also inhibit CDK6 transcription, leading to G1 arrest, and binds the transcriptional repressor NR1D2 to relieve its repression of APOC3. HGNC classifies the ZNHIT1 gene among HIT-type zinc fingers and SRCAP complex subunits; the mouse ortholog is Znhit1. Earlier names include zinc finger protein, subfamily 4A (HIT domain containing), member 1.
ZNHIT1 promotes H2AZ1 incorporation into chromatin and supports SRCAP complex activity, making it a useful factor for studying histone variant deposition.
It maintains haematopoietic and intestinal stem cell programmes by controlling H2AZ1 deposition at key fate-determining genes.
ZNHIT1 contributes to lymphoid, muscle, germ cell, neural, lens and cardiac development through regulation of lineage-specific gene expression.
It enhances p53-dependent apoptosis and CDKN1A activation, and represses CDK6, linking it to DNA damage and G1 arrest.
ZNHIT1 promotes the incorporation of histone variant H2AZ1 into chromatin, including SRCAP complex-mediated deposition, to regulate gene expression. This supports stem cell maintenance, lineage commitment, meiosis entry, heart function and p53-dependent responses such as apoptosis and cell cycle arrest.
The ZNHIT1 gene is also known as CG1I, ZNFN4A1, H_DJ0747G18.14 and p18(Hamlet). Previous names include zinc finger protein, subfamily 4A (HIT domain containing), member 1. UniProt lists the protein as zinc finger HIT domain-containing protein 1, a member of the ZNHIT1 family.
A mouse ortholog, Znhit1, is recorded, and much of the functional work summarised in UniProt concerns its roles in development and stem cells. Check the datasheet of any product for its validated reactivity.
Histone variants, SRCAP complex partners, p53 pathway components and differentiation regulators connected to ZNHIT1 function.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43257; product specifications from Assay Genie datasheets.